Panel Discussion: Reimagine the Healthcare of Tomorrow

2 July, 8PM SGT/ 1PM BST

The final episode of “The Future of Healthcare” series will end with CMO dialogue, lead by Dr Ian Chuang, Chief Medical Officer, Elsevier together with CMO across different regions. This will be live panel discussions where our guests will discuss on : How are they preparing for the new norm in healthcare delivery, what are their strategy and framework for digital transformations, their challenges, and opportunities within their own region? How can we work collaboratively towards the new norm?

Key Takeaways:

  1. As every healthcare system is tapping into and accelerating the adoption of telehealth, the panelists discuss some of the learnings that we obtain and share their opinions on why eHealth and not Telehealth is the future of remote care.
    • Dr Shah: COVID-19 has shown us that we’ve managed to accelerate things that are already within our reach, and this isn’t necessarily transformational. Telehealth is more of a transference – one mode of consultation to another. For the acceleration that we had during COVID-19 to be sustainable, we need better infrastructure, better digital penetration, and a greater use of the ecosystem of products and applications of devices that are connected up, combined with clinical pathway design that's designed around a digital workflow, not just a physical workflow that's been transferred.
    • Prof Griffith: The potential of eHealth is absolutely extraordinary, and what we need to do post COVID-19 is to make sure that we can get and keep the momentum going, in terms of adoption and regulation.
    • Dr Ko: The challenge of telehealth in the future would be figuring out how to deliver quality signal from the provider to the user before the transaction happens, and how to convert the behavior of telehealth from single purchase to repeat interaction so that the whole ecosystem can be sustainable.
    • A/Prof Yip: In Singapore, there has been an explosion of new services, redistribution of workforce and enabled by this telehealth explosion during COVID-19.
  2. A challenge from the past webinars is the concern around accuracy of data and data integrity, the veracity of the data as well as the validity, and the standardization of data. The panelists discuss how they see data as a priority for this new reality as they compare between having more data versus small little data that is very focused, very clean and has very high integrity.
    • A/Prof Yip: Data is what gives us the ability to quantify value, in order to reduce waste, improve quality and profits beyond COVID-19. We can start small and define what we do best in terms of quality, and then move upwards the chain to see what it is that we need to do like predictive analytics, and artificial intelligence that directly affects patient care.
    • Dr Ko: The first priority for making data actionable, especially in the major crisis of COVID-19, is to maintain a collaborative, but trusted platform for professional information. Leveraging this platform, professional information could be collaboratively inspected or reviewed so that, together, we can make the role of information trustworthy.
    • Dr Shah: There's a massive role for using data to improve outcomes, reduce inequalities and support transformation. But to do that, we must get much better at refining the quality of that data and making sure that data relates to a better outcome. That means moving away from traditional code sets towards evolving code sets.
    • Prof Griffith: We have to be much more realistic and much more rational in the amount of data that we collect, how we use it and the quality of that data to be able to focus on caring for our patients. Because at the end of the day, that's what we're here for.
  3. In responding to COVID-19, we’ve seen our stakeholders step up – clinicians are trying to meet the demands of healthcare needs while consumers are being more engaged to navigate the healthcare system. Our panelists discuss if there is greater potential that healthcare professionals can expand their scope of skills and allow them to practice at a different level of capabilities, and the effect this will have on clinical processes and patients.
    • Prof Griffith: What’s happened from COVID-19 is that we need to refocus patients to be at the center of our attention and we need to recognize the extraordinary adaptability of healthcare professionals. It doesn't matter what your expertise is, your role in providing good health care is equally important.
    • Dr Shah: We need to be flexible for both sets of people, the clinicians working in the system, and the citizens trying to interact with the system. If we are going to move towards an eHealth ecosystem, we have to start off with the needs, the clinical need, and the emotional need, and the practical need of both of those groups, and to design the digital ecosystem around those three needs to reduce the friction, burden and make it easier.
    • A/Prof Yip: To navigate a complex system, we had to empower the citizens, and this transformed the way we interacted with patients overnight. And for the health care providers, we changed everyone's skill sets, we upgraded everyone and from this created a new workforce from our traditional workforce.
    • Dr Ko: To empower medical staff during the crisis of COVID-19, we need to have a clear and updated rationale in advance for each level in the healthcare organization. Only then will we have the chance to communicate with patients about the rationale; and with the assistance of reliable information, we can improve the information asymmetry in the crisis and empower patients in decision making.
  4. To conclude, the panelists shared their thoughts as to whether healthcare will be the same in a post COVID-19 future.
    • Dr Ko: Healthcare will not be the same again. Firstly, we need to change the way we look at the health ecosystem – how we can leverage telehealth, healthcare data to eliminate information asymmetry. Secondly, we need to manage global healthcare supply chains such that it will not be affected during crisis. Finally, it’s about planning ahead to ensure we are prepared in times of crisis.
    • Prof Griffith: COVID-19 is a wake up call for all of us. Another perspective emerging from COVID-19 is the importance of mental health issues, and I hope to see that will improve significantly after COVID-19.
    • A/Prof Yip: With COVID-19, the patient is empowered with the ability to choose who they want to see, where they want to go for their care, and the timing of the desired nature of care. For healthcare itself, the old paradigm of cheaper, better, faster, used to be not something attainable, but now it’s the time to look at the distribution of cheaper, better, faster and safer care; and look at the ratio which we want to drive our healthcare and use technology to drive it in the direction that we desire through to the outcomes that we want.
    • Dr Shah: Healthcare has not stood still for the past 2,000 years and it won’t stand still for the next 2,000 years. What COVID-19 has done is to add a little disruption in the timeline and began another phase of transformation.

Dr. Ian Chuang. Chief Medical Officer, EMEALAAP Health, Elsevier


Dr. Chuang is the global Chief Medical Officer (CMO) for Elsevier, an information analytics business within the UK-based, FTSE-listed RELX group. Dr. Chuang’s focus at Elsevier is collaborating with healthcare leaders to improve Healthcare Information Technology (HCIT) adoption, especially as it relates to clinical decision support and improving health system decisions and processes of care to improve outcomes.

Dr. Chuang’s experience spans the entire care continuum, including applied healthcare informatics, controlled medical terminology, knowledge representation, clinical decision support (CDS) and analytics. Prior to joining Elsevier, he has led roles at both strategic level management of healthcare systems and physician leadership, and hands-on implementation of process optimization at the point-of-care.  His insights cover the full spectrum of delivering knowledge-driven care, whether it is capturing and structuring data, analytics and predictive modeling, or CDS functionalities intersecting with clinical workflow.

Dr. Chuang holds a Doctor of Medicine degree from the University of Toronto and a Master’s degree in administrative medicine from University of Wisconsin. He is a Senior Fellow at the Institute of Healthcare Design Thinking and holds an adjunct assistant professor position in the Department of Biomedical and Health Informatics at the University of Missouri. He has participated in many healthcare data standards organizations, including the National Quality Forum Health Information Technology Advisory Committee (HITAC).

LinkedIn - Twitter

Dr Shao-Hua Ko, MD, MBA. Vice -Superintendent, Min-Sheng General Hospital Group, Taiwan


Dr. Shao-Hua Ko brings more than ten years of experience and engagement for patient safety in Taiwan and abroad. He has consulted extensively on healthcare quality diagnosis and improvement at international and domestic healthcare facilities, and on healthcare quality education in Taiwan and the Greater China Area.

Dr. Ko is an active senior neurosurgeon specialized in minimally invasive neurosurgery, and a certificated spine surgeon, general surgeon and trauma surgeon. In clinical leadership, he officiated as Director of the Neurosurgery division and vice-Director of the Surgery Department at a regional teaching hospital in Taiwan, where he currently leads the quality activities as Vice-Superintendent for Quality and Administration.

Due to his MD/MBA background, Dr. Ko is also specialized in healthcare management and strategy, integration and innovation/renovation of healthcare facilities and systems, as well as patient safety system engineering, and service protocol design.

Dr. Ko’s experience in leadership roles has given him a wide understanding of issues faced by patients, medical professionals, and healthcare systems, skills that are indispensable in his work as a Joint Commission International Surveyor.

Assoc Professor  Jane Griffith. Chief Nursing Information Officer. CEO Office, Dubai Healthcare Corporation. Middle East


Jane is a registered general nurse from Australia. She has been based in the UAE since 2007 working for the Dubai Health Authority. Her clinical experience and qualifications are in Operating Theatre Techniques and Management and her academic qualifications are:

  • Associate Diploma Nursing Studies UNE(Administration).
  • Diploma of Administration (Nursing).UNE
  • Bachelor of Administration UNE
  • Master of Health Planning.UNSW

Jane’s experience has included both operational roles such as Director of Nursing and General Manager positions in tertiary level facilities as well as strategic roles in health care, facility planning, informatics and disaster management in Australia, Qatar and the UAE. Her current role is the Chief Nursing Information Officer for DHA, responsible for the Salama EMR project and standardization of clinical workflows across all DHA facilities.

Jane chairs the UAE Nursing and Midwifery Council Scientific Committees for Research and Excellence and participates in a number of UAE Boards and Councils.

Jane also has extensive academic experience in teaching and research at Universities in Australia, Ireland and USA with over 25 scientific publications and is a HIMSS Future50 Healthcare IT Leader

Prof James Yip. Group Chief Medical Information Officer of NUHS, Chief Data Advisor of the Ministry of Health, Singapore


Graduated from National University of Singapore in 1991 and trained in  Cardiology at the National University Hospital, Singapore. He was a clinical fellow in Toronto Congenital Cardiac Centre for Adults in 2001. He developed the Cardiology Information System which is in use in 3 public hospitals in Singapore. For this work and in Closed loop medication management systems (CLMMS), he has won for NUH the National Infocomm awards for best use for infocomm technology in the public sector  in 2004 and 2010. In 2012 and 2018, he was part of the team award for the National Medical Excellence award (NMEA) for CLMMS and Value driven Outcomes (VDO). He is also the individual recipient of  the 2015 Outstanding clinical quality activist for NMEA. He currently serves as the Group Chief Medical Information Officer of NUHS and is the Chief Data Advisor of the Ministry of Health. He has special interests in the area of Telemedicine and Population Analytics.

Dr Sam Shah, Global Clinical and Digital Advisor Healthcare UK. Department for International Trade


Dr Sam Shah is the Global Clinical and Digital Advisor, Healthcare UK at the Department for International Trade (DIT) and a NHS Consultant. He was previously Director of Digital Development for NHSX. Sam has worked on a number of initiatives across the NHS, including the flagship project to digitise urgent care. He had two main portfolios in the NHS spanning digital development of the health ecosystem and some national technology programmes. He has supported the development and adoption of a number of technology projects in England but has also worked with digital health start-ups from across the world. Sam is one of the inaugural members of the NHS Digital Academy. As a clinician with a background in primary healthcare and public health with a focus on designing services through a citizen-centric approach

Calendar of all webinars

10 June,
8PM SGT / 10 AM BST / 9am Brazil Time

Digital transformation and innovation in times of COVID19

Watch video

11 June 2020,
8PM ( SGT) / 1 PM (BST) / 5:30 (IST)

Innovations in radiology post COVID19

Watch video

1 July, 9 PM SGT/ 2 PM BST / 8 AM CDT

Healthcare Quality in our Changed World

Watch video